Zobrazeno 1 - 10
of 633
pro vyhledávání: '"E, Albano"'
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4bf77f8992dfb138f2b8e545418face
https://doi.org/10.7759/cureus.35169
https://doi.org/10.7759/cureus.35169
Autor:
B. Foglia, S. Cannito, S. Sutti, J. Nurcis, C. Turato, M. Maggiora, F. Doto, C. Rosso, P. Carucci, S. Gaia, A. Biasiolo, P. Pontisso, E. Bugianesi, E. Albano, M. Parola
Publikováno v:
Digestive and Liver Disease. 55:S34
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::630e81a526d3415e83dd22875a4310ea
https://doi.org/10.1016/j.dld.2023.01.066
https://doi.org/10.1016/j.dld.2023.01.066
Autor:
Linda Ceccarelli, Santino Marchi, Lorenzo Bertani, E. Albano, Giovanni Baiano Svizzero, Francesco Costa, Massimo Bellini, Federico Zanzi, Maria Gloria Mumolo, G. Tapete
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:1091-1098
Fecal calprotectin has been widely studied in inflammatory bowel disease (IBD) under clinical and therapeutic settings. It showed a good correlation with clinical, endoscopic, and histologic findings. For these reasons, fecal calprotectin is currentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56246c2e237f66c096b372c288bcb6cd
https://doi.org/10.1097/meg.0000000000001731
https://doi.org/10.1097/meg.0000000000001731
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
B. Foglia, S. Sutti, S. Cannito, M. Maggiora, C. Bocca, F. Protopapa, E. Novo, N.N. Ramavath, C. Rosso, R. Younes, E. Bugianesi, F. Tacke, W. Jahnen-Dechent, E. Albano, M. Parola
Publikováno v:
Digestive and Liver Disease. 54:S38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::316c46f2a0af77393553a323ea6494ce
https://doi.org/10.1016/j.dld.2022.01.074
https://doi.org/10.1016/j.dld.2022.01.074
Autor:
Santino Marchi, Nicola de Bortoli, Riccardo Morganti, Federico Zanzi, Lorenzo Bertani, Francesco Costa, E. Albano, Giovanni Baiano Svizzero, Massimo Bellini, Linda Ceccarelli, Maria Gloria Mumolo, Corrado Blandizzi, Francesca Coppini, G. Tapete
Publikováno v:
Clinical and Translational Gastroenterology
INTRODUCTION: Biological therapies are widely used for the treatment of ulcerative colitis. However, only a low proportion of patients achieve clinical remission and even less mucosal healing. There is currently scarce knowledge about the early marke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a58c77f40ab072e5a552723e2026764c
http://europepmc.org/articles/PMC7263645
http://europepmc.org/articles/PMC7263645
Autor:
Matteo Fornai, Corrado Blandizzi, Santino Marchi, Lorenzo Bertani, Ersilia Lucenteforte, Linda Ceccarelli, Francesco Costa, E. Albano, Luca Antonioli, Massimo Bellini, Maria Gloria Mumolo, Laura Baglietto, Nicola de Bortoli, G. Tapete, Carolina Pellegrini
Publikováno v:
Br J Clin Pharmacol
Aims Vedolizumab (VDZ) prevents migration of activated leucocytes into inflamed mucosa. This study aimed to assess the patterns of serum cytokines in ulcerative colitis (UC) patients at baseline and during VDZ treatment, and to investigate their asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f10f424de592a06a4facee67be2fb418
http://hdl.handle.net/11568/1036022
http://hdl.handle.net/11568/1036022
Autor:
Edoardo Savarino, Lorenzo Bertani, Maria Giulia Demarzo, Chiara Brombin, E. Albano, G. Tapete, Santino Marchi, Federico Rossari, Linda Ceccarelli, Brigida Barberio, Giovanni Baiano Svizzero, Francesco Costa, Massimo Bellini, Maria Gloria Mumolo, Nicola de Bortoli, Giorgia Bodini
Background Anti-tumor necrosis factor drugs (anti-TNFs) are widely used for the treatment of ulcerative colitis (UC). However, many patients experience loss of response during the first year of therapy. An early predictor of clinical remission and mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69cd66e572bb6b3760276bb26a903658
http://hdl.handle.net/11577/3368823
http://hdl.handle.net/11577/3368823
Autor:
G. Laino, Lorenzo Bertani, Giorgia Di Fluri, Linda Ceccarelli, G. Tapete, Francesco Costa, Maria Gloria Mumolo, E. Albano
Publikováno v:
World Journal of Gastroenterology
Fecal calprotectin (FC) has emerged as one of the most useful tools for clinical management of inflammatory bowel diseases (IBD). Many different methods of assessment have been developed and different cut-offs have been suggested for different clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a2f255c670a3f2357fedf0990a162e
http://europepmc.org/articles/PMC6127662
http://europepmc.org/articles/PMC6127662
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.